HEADER HYDROLASE/INHIBITOR 22-JUN-12 4AYV TITLE HUMAN THROMBIN - INHIBITOR COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: THROMBIN LIGHT CHAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGHT CHAIN, RESIDUES 332-361; COMPND 5 SYNONYM: COAGULATION FACTOR II; COMPND 6 EC: 3.4.21.5; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: THROMBIN HEAVY CHAIN; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: HEAVY CHAIN, RESIDUES 364-620; COMPND 11 SYNONYM: COAGULATION FACTOR II; COMPND 12 EC: 3.4.21.5; COMPND 13 OTHER_DETAILS: ASN B53 IS GLYCOSYLATED; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: HIRUDIN-3A'; COMPND 16 CHAIN: D; COMPND 17 FRAGMENT: C-TERMINUS, RESIDUES 55-65; COMPND 18 SYNONYM: HIRUDIN, HIRUDIN IIIA'; COMPND 19 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 7 ORGANISM_COMMON: HUMAN; SOURCE 8 ORGANISM_TAXID: 9606; SOURCE 9 MOL_ID: 3; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: HIRUDO MEDICINALIS; SOURCE 12 ORGANISM_COMMON: MEDICINAL LEECH; SOURCE 13 ORGANISM_TAXID: 6421 KEYWDS HYDROLASE-INHIBITOR COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR D.W.BANNER,A.D'ARCY,F.K.WINKLER,K.HILPERT REVDAT 4 29-JUL-20 4AYV 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE REVDAT 3 28-JUN-17 4AYV 1 REMARK REVDAT 2 07-AUG-13 4AYV 1 REMARK REVDAT 1 15-AUG-12 4AYV 0 JRNL AUTH K.HILPERT,J.ACKERMANN,D.W.BANNER,A.GAST,K.GUBERNATOR, JRNL AUTH 2 P.HADVARY,L.LABLER,K.MULLER,G.SCHMID,T.B.TSCHOPP JRNL TITL DESIGN AND SYNTHESIS OF POTENT AND HIGHLY SELECTIVE THROMBIN JRNL TITL 2 INHIBITORS. JRNL REF J.MED.CHEM. V. 37 3889 1994 JRNL REFN ISSN 0022-2623 JRNL PMID 7966150 JRNL DOI 10.1021/JM00049A008 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0025 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 84.0 REMARK 3 NUMBER OF REFLECTIONS : 11365 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.143 REMARK 3 R VALUE (WORKING SET) : 0.141 REMARK 3 FREE R VALUE : 0.192 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 588 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 499 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 51.86 REMARK 3 BIN R VALUE (WORKING SET) : 0.1910 REMARK 3 BIN FREE R VALUE SET COUNT : 32 REMARK 3 BIN FREE R VALUE : 0.2930 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2424 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 58 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.13000 REMARK 3 B22 (A**2) : -0.13000 REMARK 3 B33 (A**2) : 0.27000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.629 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.275 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.150 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.552 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2560 ; 0.009 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3464 ; 1.382 ; 1.987 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 297 ; 6.246 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 122 ;36.733 ;23.525 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 446 ;16.676 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;18.862 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 355 ; 0.093 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2044 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS GENERATED AT RIDING POSITIONS REMARK 3 IN REFMAC BUT NOT OUTPUT. RESIDUES B153 AND B154 HAVE ELECTRON REMARK 3 DENSITY WHICH IS HARD TO FIT WITH THE PUBLISHED THROMBIN REMARK 3 SEQUENCE. REMARK 4 REMARK 4 4AYV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-JUN-12. REMARK 100 THE DEPOSITION ID IS D_1290052939. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-OCT-93 REMARK 200 TEMPERATURE (KELVIN) : 15 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ELLIOTT GX-21 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : MULTIWIRE XENTRONICS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12962 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : 2.290 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: SOME DATA PROCESSING INFORMATION HAS BEEN LOST REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 70.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.25000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 45.40000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 45.40000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 99.37500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 45.40000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 45.40000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 33.12500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 45.40000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 45.40000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 99.37500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 45.40000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 45.40000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 33.12500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 66.25000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 15 -91.26 -127.87 REMARK 500 ILE A 33 52.11 -115.49 REMARK 500 ASN B 53 75.94 -156.50 REMARK 500 ASN B 95 10.44 -156.18 REMARK 500 VAL B 152 -71.33 -128.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B1260 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ARG B 233 O REMARK 620 2 LYS B 236 O 99.0 REMARK 620 3 HOH B2043 O 167.8 77.7 REMARK 620 4 HOH B2044 O 83.0 93.1 85.4 REMARK 620 5 HOH B2046 O 90.3 80.1 100.6 169.7 REMARK 620 6 HOH B2050 O 101.0 157.1 84.9 100.2 88.7 REMARK 620 N 1 2 3 4 5 REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: {BENZYL-[(S)-3-[((S)-1-CARBAMIMIDOYL-PIPERIDIN-3- REMARK 630 YLMETHYL)-CARBAMOYL]-2-(NAPHTHALENE-2-SULFONYLAMINO)-PROPIONYL]- REMARK 630 AMINO}-ACETIC ACID REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 9MQ B 1258 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 04P ASN NAS 04Q REMARK 630 DETAILS: NULL REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "BB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4AYY RELATED DB: PDB REMARK 900 HUMAN THROMBIN - INHIBITOR COMPLEX REMARK 900 RELATED ID: 4AZ2 RELATED DB: PDB REMARK 900 HUMAN THROMBIN - INHIBITOR COMPLEX REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE N-TERMINAL RESIDUE IS MODIFIED IN CHAIN D. PLEASE REFER REMARK 999 TO THE CITATION FOR FURTHER DETAILS. DBREF 4AYV A 5 34 UNP P00734 THRB_HUMAN 332 361 DBREF 4AYV B 1 257 UNP P00734 THRB_HUMAN 364 620 DBREF 4AYV D 1 11 UNP P28508 HIR3P_HIRME 55 65 SEQRES 1 A 30 GLY GLU ALA ASP CYS GLY LEU ARG PRO LEU PHE GLU LYS SEQRES 2 A 30 LYS SER LEU GLU ASP LYS THR GLU ARG GLU LEU LEU GLU SEQRES 3 A 30 SER TYR ILE ASP SEQRES 1 B 257 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 B 257 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 B 257 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 B 257 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 B 257 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 B 257 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 B 257 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 B 257 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 B 257 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 B 257 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 B 257 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 B 257 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 B 257 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 B 257 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 B 257 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 B 257 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 B 257 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 B 257 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 B 257 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 B 257 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE SEQRES 1 D 11 ASP PHE GLU GLU ILE PRO GLU GLU TYR LEU GLN MODRES 4AYV ASN B 53 ASN GLYCOSYLATION SITE HET 9MQ B1258 43 HET NAG B1259 14 HET NA B1260 1 HETNAM 9MQ {BENZYL-[(S)-3-[((S)-1-CARBAMIMIDOYL-PIPERIDIN-3- HETNAM 2 9MQ YLMETHYL)-CARBAMOYL]-2-(NAPHTHALENE-2-SULFONYLAMINO)- HETNAM 3 9MQ PROPIONYL]-AMINO}-ACETIC ACID HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM NA SODIUM ION FORMUL 4 9MQ C30 H36 N6 O6 S FORMUL 5 NAG C8 H15 N O6 FORMUL 6 NA NA 1+ FORMUL 7 HOH *58(H2 O) HELIX 1 1 PHE A 15 SER A 19 5 5 HELIX 2 2 THR A 24 SER A 31 1 8 HELIX 3 3 TYR A 32 ASP A 34 5 3 HELIX 4 4 ALA B 41 CYS B 44 5 4 HELIX 5 5 PRO B 48 ASP B 51 5 4 HELIX 6 6 THR B 55 ASN B 57 5 3 HELIX 7 7 ASP B 122 LEU B 130 1 9 HELIX 8 8 GLU B 169 SER B 176 1 8 HELIX 9 9 LYS B 191 GLY B 195 5 5 HELIX 10 10 LEU B 246 PHE B 257 1 12 SHEET 1 BA 7 SER B 5 ASP B 6 0 SHEET 2 BA 7 GLN B 161 PRO B 166 -1 O VAL B 162 N SER B 5 SHEET 3 BA 7 LYS B 135 GLY B 140 -1 O GLY B 136 N LEU B 165 SHEET 4 BA 7 PRO B 208 LYS B 212 -1 O PRO B 208 N THR B 139 SHEET 5 BA 7 TRP B 219 TRP B 227 -1 O TYR B 220 N MET B 211 SHEET 6 BA 7 GLY B 238 HIS B 242 -1 O PHE B 239 N SER B 226 SHEET 7 BA 7 MET B 185 ALA B 188 -1 O PHE B 186 N TYR B 240 SHEET 1 BB 7 GLN B 15 ARG B 20 0 SHEET 2 BB 7 GLU B 25 LEU B 32 -1 O GLU B 25 N ARG B 20 SHEET 3 BB 7 TRP B 37 THR B 40 -1 O LEU B 39 N SER B 31 SHEET 4 BB 7 ALA B 101 LEU B 105 -1 O ALA B 101 N THR B 40 SHEET 5 BB 7 LYS B 77 ILE B 86 -1 N GLU B 82 O LYS B 104 SHEET 6 BB 7 LEU B 59 ILE B 63 -1 O LEU B 59 N LEU B 81 SHEET 7 BB 7 GLN B 15 ARG B 20 -1 O MET B 17 N ARG B 62 SHEET 1 BC 2 LEU B 46 TYR B 47 0 SHEET 2 BC 2 LYS B 52 ASN B 53 -1 O LYS B 52 N TYR B 47 SSBOND 1 CYS A 9 CYS B 119 1555 1555 2.06 SSBOND 2 CYS B 28 CYS B 44 1555 1555 2.02 SSBOND 3 CYS B 173 CYS B 187 1555 1555 2.04 SSBOND 4 CYS B 201 CYS B 231 1555 1555 2.03 LINK ND2 ASN B 53 C1 NAG B1259 1555 1555 1.45 LINK O ARG B 233 NA NA B1260 1555 1555 2.56 LINK O LYS B 236 NA NA B1260 1555 1555 2.11 LINK NA NA B1260 O HOH B2043 1555 1555 2.33 LINK NA NA B1260 O HOH B2044 1555 1555 3.05 LINK NA NA B1260 O HOH B2046 1555 1555 2.55 LINK NA NA B1260 O HOH B2050 1555 1555 2.20 CISPEP 1 SER B 22 PRO B 23 0 -5.50 CISPEP 2 LYS B 154 GLY B 155 0 10.64 CRYST1 90.800 90.800 132.500 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011013 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011013 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007547 0.00000